Results 11 to 20 of about 179,854 (236)
Substandard and counterfeit medicines: a systematic review of the literature [PDF]
BMJ Open, 2013 ObjectiveTo explore the evidence available of poor-quality (counterfeit and substandard) medicines in the literature.DesignSystematic review.Data sourcesDatabases used were EMBASE, MEDLINE, PubMed and the International Pharmaceutical Abstracts, including articles published till January 2013.Eligibility criteriaPrevalence studies containing original ...
Imti Choonara, Helen Sammons
exaly +7 more sources
A systematic review of counterfeit and substandard medicines in field quality surveys [PDF]
Integrated Pharmacy Research & Practice, 2014 Abdulaziz Fahad Abdulaziz Alghannam, Zoe Aslanpour, Sara Evans, Fabrizio Schifano Department of Pharmacy, University of Hertfordshire, Hatfield, Hertfordshire, United Kingdom Objectives: Counterfeit and substandard medicines pose a great threat to ...
Fabrizio Schifano
exaly +4 more sources
Combatting substandard and falsified medicines: a view from Rwanda. [PDF]
PLoS Medicine, 2013 Agnes Binagwaho and colleagues describe Rwanda's experience of pharmacovigilance for malaria and tuberculosis, and call for a global treaty and leadership by the World Health Organization to address the global manufacture and trade in substandard and falsified medicines.
Agnes Binagwaho +10 more
doaj +6 more sources
Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
JMIR Public Health and Surveillance, 2021 The World Health Organization and others warn that substandard and falsified medicines harm health and waste money, especially in low- and middle-income countries.
Elizabeth Pisani +5 more
doaj +2 more sources
Substandard, falsified and unregistered medicines in Latin America, 2017-2018 [PDF]
Revista Panamericana de Salud Pública, 2020 Objective. To assess all the incidents of substandard, falsified and unregistered medicines in 2017 and 2018 in Latin America, determining the types of products affected, stages of the supply chain in which incidents were detected, quality deviations ...
Robin Rojas-Cortés
doaj +3 more sources
Current scenario of spurious and substandard medicines in India: a systematic review. [PDF]
Indian J Pharm Sci, 2015 Globally, every country is the victim of substandard or spurious drugs, which result in life threatening issues, financial loss of consumer and manufacturer and loss in trust on health system. The aim of this enumerative review was to probe the extent on poor quality drugs with their consequences on public health and the preventive measures taken by ...
Khan AN, Khar RK.
europepmc +4 more sources
Substandard and falsified medicine screening technologies [PDF]
AAPS Open, 2019 Substandard and falsified medicine screening technologies are invaluable tools for post-marketing surveillance of medicine quality, particularly in low- and middle-income countries.
Lukas Roth +2 more
doaj +2 more sources
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance [PDF]
Nature Communications, 2023 Approximately 10% of antimicrobials used by humans in low- and middle-income countries are estimated to be substandard or falsified. In addition to their negative impact on morbidity and mortality, they may also be important drivers of antimicrobial ...
Sean Cavany +9 more
doaj +2 more sources
Is this pill safe? Substandard medicines, mistaken solutions. [PDF]
CMAJ, 2011 In most developing countries you can buy prescription medicines from street vendors and in corner stores, with no need for a doctor’s note and with only the untutored vendor’s suggestions as to dosage and side effects. You might well wonder about safety.
Fried M.
europepmc +4 more sources
Frontiers in Pharmacology, 2018 Substandard and falsified (SF) medicines have emerged as a global public health issue within the last two decades especially in low- and middle-income countries (LMICs). Serious consequences of this problem include a loss of trust and increased financial
Ulrike Holzgrabe
exaly +3 more sources